Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Strong Economic Data Sparks Sell-Off in S&P 500

Dieter Jaworski by Dieter Jaworski
September 26, 2025
in Analysis, Market Commentary, S&P 500
0
S&P 500 Stock
0
SHARES
98
VIEWS
Share on FacebookShare on Twitter

A batch of unexpectedly robust U.S. economic indicators prompted a wave of selling on Thursday, pulling the S&P 500 down by 0.5%. The benchmark index closed the session at 6,604.72, a decline of 33.25 points, as investors grew concerned that the strong data could delay interest rate cuts from the Federal Reserve.

Market Breadth Signals Widespread Caution

The session marked the third consecutive day of losses for the index, following a series of record highs earlier in the week. The negative sentiment was broad-based, with declining issues outnumbering advancers by a ratio of 3.11 to 1 on the NYSE and 3 to 1 on the Nasdaq. The heightened selling pressure was further evidenced by trading volume, which reached 19.58 billion shares, significantly exceeding the 20-day average.

Selective Gains Amid a Broad Decline

Despite the overall downward trend, several individual stocks posted substantial gains, driven by company-specific news.
* Intel surged as much as 9% amid speculation of a potential investment from Apple.
* IBM advanced over 5% following positive announcements related to its quantum computing collaboration with HSBC.
* Other notable performers included Albemarle (+5.80%), Synopsys (+3.03%), and Charles Schwab (+2.28%).

However, these gains were overshadowed by significant losses elsewhere.
* CarMax plummeted more than 20% after reporting disappointing quarterly results.
* Freeport-McMoRan declined nearly 17%.
* Major technology stocks continued to struggle, with Oracle falling 5.6% and Tesla dropping 4%.

Should investors sell immediately? Or is it worth buying S&P 500?

Technical Support Levels Come Into View

From a technical analysis perspective, the recent upward trend has been challenged. Although the index remains above its 50-day moving average of 6,446, key support levels at 6,611 and 6,506 are now in focus. A sustained break below 6,611 could pave the way for a test of 6,500 and potentially 6,460. While weekly and monthly RSI readings suggest underlying momentum is still intact, the daily Average Directional Index (ADX) indicates the current trend is losing strength—a view supported by the session’s volume analysis.

Macroeconomic Data Fuels Rate Concerns

The primary driver behind the investor retreat was a set of macroeconomic reports that painted a picture of a resilient U.S. economy.
* The second estimate for second-quarter GDP was revised upward to an annualized rate of 3.8%.
* Weekly initial jobless claims unexpectedly fell to 218,000.
* Orders for durable goods showed a recovery.

This strong data has led markets to question the likelihood of imminent Fed easing. In response, the yield on the benchmark 10-year U.S. Treasury note climbed to 4.18%. Simultaneously, the U.S. Dollar Index jumped 0.7% to a three-week high of 98.52, creating an additional headwind for equity valuations.

Attention now turns to Friday’s release of the August Core PCE Price Index, the Federal Reserve’s preferred inflation gauge. Any surprise deviation from forecasts could significantly amplify the current market anxiety surrounding the future path of interest rates.

Ad

S&P 500 Stock: Buy or Sell?! New S&P 500 Analysis from February 8 delivers the answer:

The latest S&P 500 figures speak for themselves: Urgent action needed for S&P 500 investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 8.

S&P 500: Buy or sell? Read more here...

Tags: S&P 500
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Quanterix Stock
Analysis

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Next Post
Cardiff Oncology Stock

Cardiff Oncology Shares Face Sustained Selling Pressure

Fannie Mae Stock

Political Headwinds Buffet Fannie Mae's Path to Privatization

Unitedhealth Stock

UnitedHealth Navigates Legal Challenges While Pursuing Growth Initiatives

Recommended

Biotechnology Stock Exchange

Analysts Bullish on Dynatrace with Price Targets on the Rise

2 years ago
The Trade Desk Stock

The Trade Desk Faces Mounting Pressure as Amazon Strikes Netflix Deal

5 months ago

Analyst Reaffirms Buy Rating on International Seaways with 66 Price Target

2 years ago
Biotechnology Stock Bull Market

KeyBanc Analyst Raises Price Target and Maintains Overweight Rating on Repligen NASDAQ RGEN

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Trending

Puma Biotechnology Stock
Earnings

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

by Jackson Burston
February 8, 2026
0

Investor attention is now firmly fixed on February 26, 2026, as Puma Biotechnology prepares to release its...

Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Puma Biotechnology Sets Date for Full-Year Financial Disclosure
  • Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test
  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com